Health-related Quality of Life in Rare Kidney Stone

• Register: ClinicalTrials.gov
• Last refreshed on: 12 September 2022
• Main ID: NCT02124395
• Date of registration: 23/04/2014
• Prospective Registration: No
• Primary sponsor: NYU Langone Health
• Public title: Health-related Quality of Life in Rare Kidney Stone
• Scientific title: Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium
• Date of first enrolment: August 2013
• Target sample size: 365
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02124395
• Study type: Observational [Patient Registry]

Countries of recruitment

Iceland, United States

Contacts

• Name: David Goldfarb, MD
• Affiliation: NYU Langone Health

Key inclusion & exclusion criteria

Inclusion Criteria:

- Qualify to participate in one of the Rare Kidney Stone Registries.

- Be at least 5 years old (for SF-10)

- Are able to communicate using the English language

- Consent to participate in the study (or "assent" if under 18 years old)

- Have internet access with an email account or a valid home address

Exclusion Criteria:

None, if inclusion criteria are met



Age minimum: 5 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Adenine Phosphoribosyl Transferase Deficiency

Dent Disease

Cystinuria

Primary Hyperoxaluria

Intervention(s)

Other: Health-related Quality of Life in Rare Kidney Stone Questionnaire

Primary Outcome(s)

Assessment of HRQoL in patients with rare kidney stones [Time Frame: Once a year for up to 5 years after signed consent]

Secondary ID(s)

13-00968

1U54DK083908-01

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)